Cwl0971, a novel peptidoglycan hydrolase, plays pleiotropic roles in Clostridioides difficile R20291. (24th April 2021)

• Record Type: Journal Article
• Authors: Zhu, Duolong; Patabendige, Hiran Malinda Lamabadu Warnakulasuriya; Tomlinson, Brooke Rene; Wang, Shaohui; Hussain, Syed; Flores, Domenica; He, Yongqun; Shaw, Lindsey N.; Sun, Xingmin
• Is Part Of: Environmental microbiology. Volume 23:Number 9(2021)
• Page Start: 5222
• Page End: 5238
• Publication Date: 2021-04-24
• Subjects: Microbial ecology -- Periodicals; Environmental Microbiology -- Periodicals; 579.17
• DOI: 10.1111/1462-2920.15529
• Languages: English
• ISSNs: 1462-2912

Abstract

Summary: Clostridioides difficile is a Gram‐positive, spore‐forming, toxin‐producing anaerobe that can cause nosocomial antibiotic‐associated intestinal disease. Although the production of toxin A (TcdA) and toxin B (TcdB) contribute to the main pathogenesis of C . difficile, the mechanism of TcdA and TcdB release from cell remains unclear. In this study, we identified and characterized a new cell wall hydrolase Cwl0971 ( CDR20291_0971 ) from C . difficile R20291, which is involved in bacterial autolysis. The gene 0971 deletion mutant (R20291Δ0971) generated with CRISPR‐AsCpfI exhibited significantly delayed cell autolysis and increased cell viability compared to R20291, and the purified Cwl0971 exhibited hydrolase activity for Bacillus subtilis cell wall. Meanwhile, 0971 gene deletion impaired TcdA and TcdB release due to the decreased cell autolysis in the stationary/late phase of cell growth. Moreover, sporulation of the mutant strain decreased significantly compared to the wild type strain. In vivo, the defect of Cwl0971 decreased fitness over the parent strain in a mouse infection model. Collectively, Cwl0971 is involved in cell wall lysis and cell viability, which affects toxin release, sporulation, germination, and pathogenicity of R20291, indicating that Cwl0971 could be an attractive target for C . difficile infection therapeutics and prophylactics.